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Abstract
Objective To report patients’ own experiences of receiving a diagnosis of Parkinson’s disease (PD) and to identify factors 
influencing this experience.
Methods A survey by the European Parkinson’s Disease Association in 11 European countries.
Results 1775 patients with an average age of 69.7 years participated of whom 54% were male. Those living in rural areas 
reported having waited longer to seek medical help (p < 0.05). A possible diagnosis of PD was made at the first appointment 
in a third of respondents. When the diagnosis was made, only 50% reported that the diagnosis was communicated sensitively. 
38% of patients reported having been given enough time to ask questions and discuss concerns, but 29% did not. 98% of 
participants reported having been given information about PD at the time of diagnosis but 36% did not find the information 
given helpful. Patient satisfaction with the diagnostic consultation was positively associated with more sensitive delivery of 
diagnosis, the helpfulness and quantity of the information provided and time to ask questions (all p < 0.001). Where diag-
nosis was given by a specialist, participants reported greater perceived satisfaction with the diagnostic consultation, greater 
sensitivity of communicating the diagnosis, time to ask questions, provision and helpfulness of information, and earlier 
medication prescription (all p < 0.0001).
Conclusions There is a need to improve how the diagnosis of PD is communicated to patients, the opportunity to ask ques-
tions soon after diagnosis, and the amount, timing and quality of life information provided, as this is associated with greater 
satisfaction with the diagnostic process.
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Introduction
The experience of receiving a diagnosis of Parkinson’s dis-
ease (PD) has been reported to have a significant impact 
on patients’ quality of life even many years after the initial 
diagnosis [1]. Several aspects of the diagnostic process, 
including time to diagnosis, the referral process, how it is 
reached, the way it is communicated, the information pro-
vided and explained, the follow-up actions planned and 
the treatments started are all likely to be factors that can 
influence the impact of the diagnosis [2]. However, how the 
diagnostic process is experienced from the patient’s point 
of view and which factors influence their experience of the 
diagnostic process have received little attention. To improve 
the experience of receiving a diagnosis of PD and to miti-
gate its long-term impact, it is important to understand how 
patients experience this process and what aspects are of 
relevance from their point of view. This information will 
allow health care professionals involved in the diagnostic 
process improve the experience and impact of this diagnosis 
for patients.
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We here report the results of a large survey in people with 
PD from 11 European countries on their subjective experi-
ences of receiving a diagnosis of PD.
Methods
Between 1st November 2014 and 12th January 2015, the 
European Parkinson’s Disease Association (EPDA) con-
ducted a survey in patients with PD through its national 
patient organisations from 11 countries (Germany, France, 
Holland, Sweden, UK, Ireland, Slovenia, Spain, Italy, Hun-
gary, and Denmark). Participants completed a self-reported 
online survey (except in Slovenia where, due to low internet 
access, hard copies of the survey were distributed via the 
national Parkinson’s Association). This included questions 
on demographics, disease duration and initial symptoms, on 
experiences of initial diagnosis and what healthcare profes-
sional made the diagnosis, how sensitively the diagnosis was 
given, opportunity to ask questions, information provided 
in the consultation, medication prescribed and on satisfac-
tion with the diagnostic consultation (see Supplementary 
Material).
Data analysis
Descriptive results are presented as total numbers and per-
centages and mean with standard deviation (SD) or median 
(range), if not normally distributed. Correlations were 
examined using Spearman rank correlations and frequen-
cies compared using Chi-square tests. Groups were com-
pared using Mann–Whitney U test and Kruskal–Wallis H 
tests. Significance level was set at 5%. All analyses were 
conducted using SPSS (versions 21 and 24).
Results
1775 patients completed the survey. Participant character-
istics are given in Table 1. Average age was 69.7 (SD 56.3) 
years with a median disease duration of 7 (< 1 to 42) years 
and 54% were male.
Lead‑up to diagnosis
29% of participants reported having waited for 12 months or 
more after first noticing symptoms before seeking medical 
help, 21% 6–12 months, 17% 3–6 months, 24% less than 
3 months and 9% could not remember how long they had 
waited. Those living in rural areas reported having waited 
longer to seek medical help than those living in a city or 
town (p = 0.007) with no differences in gender, age and 
countries, except Slovenia where patients waited longer 
(p = 0.003 compared to the UK).
Experience of diagnostic consultation
A possible diagnosis of PD was made at the first appoint-
ment in a third of respondents of the overall sample with the 
majority requiring additional appointments (Fig. 1). Eight 
percent were told they had a different diagnosis and 7% that 
nothing was wrong during their first appointment with a 
healthcare professional. Similar responses were reported in 
those diagnosed aged 50 years or younger and those older 
than 50 years at diagnosis, and in those who were diag-
nosed by a specialist or general neurologist (Supplementary 
Table 1  Characteristics of 
participants in the EPDA survey 
(N = 1775)
Mean (SD) Median (range) Country Number [n (%)]
Male [n (%)] 958 (54)
Age of onset 58.5 (10.0) 59.0 (65.0; 25–90) UK 110 (6.3)
Years since diagnosis 8.2 (6.1) 7.0 (41.0; 1–42) Holland 175 (10.1)
Years since symptom onset (%) Denmark 146 (8.4)
 < 1 year 9.4 France 47 (2.7)
 1–2 years 8.8 Hungary 66 (3.8)
 2–3 years 11.9 Germany 84 (4.8)
 3–5 years 17.0 Spain 64 (3.7)
 5–10 years 29.7 Slovenia 90 (5.2)
 > 10 years 23.3 Italy 151 (8.7)
Employed [n (%)] 333 (18.8%) Sweden 806 (46.3)
Environment [n (%)]
 Rural 343 (19.4)
 Town 655 (37.0)
 City 774 (43.7)
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Material Fig. 1). The highest numbers reporting being given 
a possible diagnosis of PD at the first appointment were in 
Hungary (48%), Holland (42%), Sweden (40%) and Den-
mark (38%; Fig. 2 Supplementary Material).
The diagnosis of PD was given most commonly by a 
neurologist, with (52%) and without specialist interest in 
PD (34%, see Supplementary Material Fig. 3 for country 
by country). 57% of the overall sample reported having had 
a brain scan at the time of diagnosis. Higher rates of brain 
scans at the time of diagnosis were reported in Germany 
(79%) and Denmark (73%) and lower rates in UK (43%) 
and France (43%).
Fifty percent of participants reported that they were told 
they had PD quite or very sensitively, but 50% felt they were 
told not very or not at all sensitively (Fig. 2). After being 
given the diagnosis of PD, 38% of patients reported hav-
ing been given enough time to ask questions and discuss 
concerns, 17% reported that they would have liked more 
time to ask questions, 12% reported not having been given 
any time for questions, 28% did not want or feel able to ask 
questions at the time and 4% could not remember. However, 
this was different between countries (p < 0.0001, Supple-
mentary Material Fig. 4). The amount of information pro-
vided at diagnosis varied, with 2% of participants reporting 
not receiving any information at diagnosis (Fig. 3). The type 
and mode of information provided were predominantly ver-
bal information on the disease, with most information on 
symptoms, diagnosis, causes of PD and medication (Fig. 3). 
Nearly half of the respondents reported that they had not 
received any information on non-drug treatments (e.g. physi-
otherapy) at diagnosis. The information provided was per-
ceived as helpful by 64% of those who were able to provide 
this information but 36% did not find the information helpful 
(see Table 2). Treatment was started mostly immediately 
after diagnosis (67%).
Satisfaction with diagnostic consultation
49 percent of the overall sample reported they were satisfied 
with the initial consultation and 29% being neutral, but 22% 
reported being dissatisfied with the consultation at diagno-
sis. Respondents in Hungary (66%), Slovenia (65%), and 
Denmark (63%) reported the highest levels of satisfaction 
with the initial consultation (see Supplementary Material 
Table 1). Patient satisfaction was strongly associated with 
more sensitive delivery of diagnosis (r = 0.65, p < 0.0001) 
and the helpfulness of the information provided (r = 0.52, 
p < 0.0001), and fairly with the time provided to ask ques-
tions (r = 0.37, p < 0.0001), the quantity of information pro-
vided (sum of areas for which information was provided, 
r = 0.29, p < 0.0001), but correlated only poorly (r < 0.2) 
with age, disease duration, age of onset, how long patients 
had waited to seek medical attention and how quickly they 
received medication after diagnosis. Those who received 
Fig. 1  Explanation at first con-
sultation (% of respondents)
 Journal of Neurology
1 3
their diagnosis at the first appointment had slightly greater 
satisfaction with the diagnostic consultation (p = 0.05) but 
there was no difference between participants with different 
employment status, habitat, gender or those who had a 
brain scan or not. Where diagnosis was given by a specialist 
PD neurologist, there was a greater perceived satisfaction 
Fig. 2  Sensitivity of com-
munication of diagnosis (% of 
respondents)*
Fig. 3  Information received at 
diagnosis (% of respondents)
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with the diagnostic consultation (p < 0.0001), sensitivity in 
delivery of diagnosis, time to ask questions, provision and 
helpfulness of information and shorter timeframe in which 
the medication was prescribed (all p < 0.0001) compared to 
general neurologists, geriatricians, hospital doctors and GP/
family doctors.
Discussion
In this large survey in several European countries, almost 
half of all patients with PD reported that they were not satis-
fied with initial diagnostic consultation. As the way the diag-
nosis is communicated has been reported to be associated 
with quality of life scores even years later [1], improving 
this experience is important in the care of patients also in 
the longer term. Demographic factors or where participants 
lived did not have a strong influence on how satisfied they 
were with the diagnostic consultation, although those living 
in rural areas and patients in Slovenia had waited longer to 
seek medical attention. A diagnosis of PD was made at the 
first appointment in a third of patients and in approximately 
a third there was diagnostic uncertainty following the first 
appointment (likely to reflect true diagnostic uncertainty or 
specialist confirmation being awaited), but a substantial pro-
portion was initially told they had a different diagnosis or 
nothing was wrong. There were some differences between 
countries in experiences at the time of first appointment that 
are likely to reflect national guidelines as well as health care 
structures and availability of resources. For example, greater 
numbers of individuals reported having had brain scans in 
Germany and France, the highest proportion of patients 
reported receiving a diagnosis and medication already at 
the initial consultation in Hungary, and the highest percent-
age of participants reported having been given enough time 
to ask questions at the initial diagnosis in Holland. However, 
whether the diagnosis was made at the first appointment or 
whether there had been a diagnostic delay only slightly influ-
enced how satisfied patients were with their diagnostic con-
sultation. In addition, whilst we only collected information 
on participants’ recollection of having had a brain scan and 
on how quickly medication was prescribed (which, therefore, 
may not represent accurate information on clinical practice), 
neither of these factors influenced satisfaction ratings. This 
suggests that whether a brain scan is performed and whether 
medication is prescribed immediately are not key factors 
for the subjective experience of receiving a diagnosis of 
PD. Of much greater importance to patient satisfaction with 
the diagnostic consultation was the time patients reported 
having had at the diagnostic consultation to ask questions, 
and how much information was provided to them on vari-
ous aspects of PD and its management. The most important 
factors, however, for how satisfied patients were with the 
diagnostic consultation, were how sensitively the diagnosis 
of PD was communicated to them and the helpfulness of 
the information about PD provided. These factors were also 
associated with communication of the diagnosis by PD spe-
cialists, who in turn had higher ratings in satisfaction with 
the diagnostic consultation.
Information on how satisfied patients were with the diag-
nostic consultation and the factors with the greatest influence 
on this provides an opportunity to improve the experience of 
being diagnosed with PD. Whilst health care professionals in 
diagnostic consultations necessarily need to focus on making 
the correct diagnosis, ordering appropriate tests and start-
ing medication, subjective patient experience of receiving a 
diagnosis of PD is primarily determined by how the diagno-
sis is communicated, the quantity and helpfulness of infor-
mation is provided and whether they have the opportunity to 
ask questions. Training in communicating a diagnosis of PD 
in a sensitive way, on how to provide information verbally 
and in written form, and giving time to ask questions in the 
consultation or shortly afterwards are important factors that 
can shape this experience. Guidelines for the management 
of PD, e.g. the NICE [3] or EFNS guidelines [4], already 
incorporate some of these recommendations such as tailored 
provision of communication, but do not specifically address 
how to communicate the diagnosis or provide sufficient time 
for questions on the diagnosis, e.g. in a follow-up or nurse 
specialist appointment.
Delivering bad or difficult news is an important aspect 
of how clinicians have influence on the impact of disease 
on the individual. Surveys in other disorders showed that 
patients wanted their doctors to be truthful, caring, and com-
passionate in communication of difficult news [5]. It has also 
been shown across medical conditions that bad news com-
municated badly can cause confusion, long-lasting distress, 
and resentment; if done well, it can assist in understanding, 
acceptance, and adjustment [6]. Guidelines emphasise the 
importance of preparation, assessing the patient’s under-
standing, giving information, follow-up and discussion of 
treatment options, and assessing patients’ emotions [6]. 
Most of these guidelines are focussed on cancer or terminal 
illness, but an increasing emphasis on delivering bad news 
is also being placed in neurology [7–9] and chronic, non-
fatal diseases. In PD, there is still a need to improve how 
the diagnosis is communicated to patients, in particular the 
Table 2  Reported helpfulness 
of information received n %
Very helpful 220 15.3
Quite helpful 534 37.1
Not very helpful 285 19.8
Not helpful 135 9.4
Cannot remember 269 18.5
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sensitivity of communication in the context of a patient’s 
understanding, emotions, and expectations. The opportunity 
to ask questions soon after diagnosis is valued by patients, 
and the amount, timing and quality of life information pro-
vided need to be adjusted to individual patients but improves 
satisfaction with the diagnostic process. This information, as 
well as specialist knowledge, is often more easily available 
to specialists, and the diagnosis is, therefore, best made and 
communicated by them, followed by a second appointment 
with a health care professional to allow questions to be asked 
about a new diagnosis of PD.
Limitations
As this was a survey on patients’ experiences of diagnosis, 
with a varying number of years since diagnosis, patients 
may not always have remembered all aspects of the diag-
nostic process accurately, particularly as they may not have 
been able to take in all information given at the time [10]. 
However, patient experience and its impact were the focus 
of this paper rather than the actual service provided to allow 
assessment of factors that can be modified to improve the 
experience. In addition, the survey was conducted through 
the national patient organisations online and participants had 
a relatively young average age; it is, therefore, likely that 
younger, more educated patients and those who are more 
active and involved in their management were also more 
likely to participate in this survey. This may have introduced 
a bias to patients with greater education and with higher 
expectations of information provision and of time given to 
ask questions. However, the sensitivity of how the diagnosis 
was communicated is unlikely to have been influenced by 
this. In addition, we did not explore the influence of fam-
ily and social factors and availability of financial and other 
societal measures on the experience of receiving a diagnosis. 
These factors are very likely to be important modifying fac-
tors as will be expectations and personality characteristics 
which we did not explore in this study.
Conclusions
Whilst referral times and time to ask questions may be influ-
enced by availability of resources in constrained health care 
systems, many of the factors identified to influence satisfac-
tion with care are not cost intensive, but could be improved 
by greater awareness and training in how to communicate a 
diagnosis and provision of information on available sources 
of information, such as in this video produced by patient 
organisations: https ://www.youtu be.com/watch ?v=9DBA5 
D5Mx7 4 and Supplementary Material. In addition, tailoring 
information to patient needs to make it most appropriate is 
likely to improve patient satisfaction with the experience of 
the initial diagnostic consultation.
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